Response to letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
Main Authors: | Gerhard Wess, Tony Glaus, VALVE Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Journal of Veterinary Internal Medicine |
Online Access: | https://doi.org/10.1111/jvim.16033 |
Similar Items
-
Response to letter to editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
by: Gerhard Wess, et al.
Published: (2021-03-01) -
Letter regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
by: Mark A. Oyama, et al.
Published: (2021-03-01) -
Letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
by: Clarke Atkins, et al.
Published: (2021-03-01) -
Effects of Pimobendan and Enalapril for Mitral Valve Disease in Dogs
by: Yuan- Jen Mai, et al.
Published: (2009) -
Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease
by: Fabio Sarcinella, et al.
Published: (2019-12-01)